Vile RG - Search Results

1

A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model.

Castleden SA, Chong H, Garcia-Ribas I, Melcher AA, Hutchinson G, Roberts B, Hart IR, Vile RG. Castleden SA, et al. Among authors: vile rg. Hum Gene Ther. 1997 Nov 20;8(17):2087-102. doi: 10.1089/hum.1997.8.17-2087. Hum Gene Ther. 1997. PMID: 9414257

2

Targeted gene therapy.

Hart IR, Vile RG. Hart IR, et al. Among authors: vile rg. Br Med Bull. 1995 Jul;51(3):647-55. doi: 10.1093/oxfordjournals.bmb.a072984. Br Med Bull. 1995. PMID: 7552086 Review.

3

Gene transfer technologies for the gene therapy of cancer.

Vile R, Russell SJ. Vile R, et al. Gene Ther. 1994 Mar;1(2):88-98. Gene Ther. 1994. PMID: 7584073 Review.

4

A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes.

Vile R, Miller N, Chernajovsky Y, Hart I. Vile R, et al. Gene Ther. 1994 Sep;1(5):307-16. Gene Ther. 1994. PMID: 7584096

5

Effects of modulators of tyrosinase activity on expression of murine interleukin-2 cDNA driven by the tyrosinase promoter.

Miller N, Vile RG, Hart IR. Miller N, et al. Among authors: vile rg. Melanoma Res. 1995 Apr;5(2):75-81. doi: 10.1097/00008390-199504000-00001. Melanoma Res. 1995. PMID: 7620342

6

Retroviruses as vectors.

Vile RG, Russell SJ. Vile RG, et al. Br Med Bull. 1995 Jan;51(1):12-30. doi: 10.1093/oxfordjournals.bmb.a072941. Br Med Bull. 1995. PMID: 7767638 Review.

7

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.

Vile RG, Nelson JA, Castleden S, Chong H, Hart IR. Vile RG, et al. Cancer Res. 1994 Dec 1;54(23):6228-34. Cancer Res. 1994. PMID: 7954471

8

Targeted therapy for malignant melanoma.

Hart IR, Vile RG. Hart IR, et al. Among authors: vile rg. Curr Opin Oncol. 1994 Mar;6(2):221-5. doi: 10.1097/00001622-199403000-00016. Curr Opin Oncol. 1994. PMID: 8011700 Review.

9

Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences.

Vile RG, Hart IR. Vile RG, et al. Ann Oncol. 1994;5 Suppl 4:59-65. doi: 10.1093/annonc/5.suppl_4.s59. Ann Oncol. 1994. PMID: 8060899

10

Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.

Vile RG, Hart IR. Vile RG, et al. Cancer Res. 1993 Sep 1;53(17):3860-4. Cancer Res. 1993. PMID: 8395331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters